Interferon Alpha-2b Therapy in Chronic Hepatitis Delta

BACKGROUND: Approximately 5% of hepatitis B virus (HBV) carriers are coinfected with hepatitis D virus (HDV). HBV/HDV coinfection is a major cause of cirrhosis and end stage liver disease in chronic HBsAg carriers. The only approved therapy for chronic hepatitis delta is interferon alpha (IFN α) in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Keshvari, Maryam, Alavian, Seyed Moayed, Sharafi, Heidar, Karimi, Gharib, Gholami Fesharaki, Mohammad
Formato: Artigo
Idioma:Inglês
Publicado em: Kowsar 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3989544/
https://ncbi.nlm.nih.gov/pubmed/24744790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5812/hepatmon.15729
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados